Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAP4K1 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-06 |
mRNA | CCDC88B | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |
mRNA | WWC1 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
mRNA | TMEM241 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | PLEK | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | ORAI2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | CORO1A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
mRNA | PLA2G15 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | MFSD5 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | FCHSD2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |